Clinical trial
Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast…
NCT03581630 · Gangnam Severance Hospital, Other · Completed
Key facts
| NCT number | NCT03581630 |
|---|---|
| Title | Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients |
| Official title | Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment on Body Weight and Metabolic Risk Factors in Obese Breast Cancer Patients After Breast Cancer Treatment |
| Lead sponsor | Gangnam Severance Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer, Obesity, Overweight |
| Intervention type | Behavioral, Drug |
| Interventions | naltrexone/bupropion, Mediterranean Diet |
| Enrollment | 72 |
| Start date | Jul 29, 2017 |
| Primary completion | Jul 22, 2018 |
| Completion | Jul 22, 2018 |
| First posted | Jul 10, 2018 |
| Last update posted | Aug 29, 2018 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: